These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19183783)
1. The role of duloxetine in the treatment of anxiety disorders. De Berardis D; Serroni N; Carano A; Scali M; Valchera A; Campanella D; D'Albenzio A; Di Giuseppe B; Moschetta FS; Salerno RM; Ferro FM Neuropsychiatr Dis Treat; 2008 Oct; 4(5):929-35. PubMed ID: 19183783 [TBL] [Abstract][Full Text] [Related]
2. Is there a role for agomelatine in the treatment of anxiety disorders?A review of published data. De Berardis D; Conti CM; Marini S; Ferri F; Iasevoli F; Valchera A; Fornaro M; Cavuto M; Srinivasan V; Perna G; Carano A; Piersanti M; Martinotti G; Di Giannantonio M Int J Immunopathol Pharmacol; 2013; 26(2):299-304. PubMed ID: 23755745 [TBL] [Abstract][Full Text] [Related]
4. Advances in Pharmacotherapy for Pediatric Anxiety Disorders. Nicotra CM; Strawn JR Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968 [TBL] [Abstract][Full Text] [Related]
5. Duloxetine for the treatment of generalized anxiety disorder: a review. Khan AY; Macaluso M Neuropsychiatr Dis Treat; 2009; 5():23-31. PubMed ID: 19557096 [TBL] [Abstract][Full Text] [Related]
6. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. Baldwin DS Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():12-5. PubMed ID: 24921677 [TBL] [Abstract][Full Text] [Related]
7. SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder? Sansone RA; Sansone LA Innov Clin Neurosci; 2011 Jun; 8(6):10-4. PubMed ID: 21779536 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the treatment of generalized anxiety disorder. Wright A; Vandenberg C Int J Gen Med; 2009 Dec; 2():153-62. PubMed ID: 20360899 [TBL] [Abstract][Full Text] [Related]
9. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. Montgomery S Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676 [TBL] [Abstract][Full Text] [Related]
11. Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder. Muscatello MRA; Zoccali RA; Pandolfo G; Mangano P; Lorusso S; Cedro C; Battaglia F; Spina E; Bruno A Front Psychiatry; 2019; 10():772. PubMed ID: 31749717 [No Abstract] [Full Text] [Related]
12. The pharmacologic treatment of anxiety disorders: a review of progress. Ravindran LN; Stein MB J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups. Dell'osso B; Camuri G; Dobrea C; Buoli M; Serati M; Altamura AC Clin Pract Epidemiol Ment Health; 2012; 8():120-5. PubMed ID: 23166563 [TBL] [Abstract][Full Text] [Related]
15. Duloxetine in the treatment of generalized anxiety disorder. Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191 [TBL] [Abstract][Full Text] [Related]